0000000000370005

AUTHOR

Michele Pavone Macaluso

showing 3 related works from this author

Intravesical gemcitabine in superficial bladder tumors. Results of a phase I-II study

2004

the good tolerability of intravesical gemcitabine have been recently published. The evaluation of the activity on a papillary marker lesion is the best tool to measure the efficacy of a drug by intravesical route against superficial transitional cell carcinoma of the bladder (TCCB). The scientific background and the ethical acceptability of this approach have been validated by the European Organization for Research and Treatment of Cancer Urological Group. The aim of the present study was to evaluate the ablative efficacy of weekly intravesical instillations of gemcitabine against a histologically proven papillary marker lesion. MATERIAL & METHODS: Twenty-seven patients, affected by recurre…

Sperfial bladder cancer intravesical chemotherapy marker lesion gemcitabineSettore MED/24 - Urologia
researchProduct

Handling and Reporting of Tissue Specimens in Urological Oncology

2003

medicine.medical_specialtybusiness.industryUrologyGeneral surgeryMedicinebusinessUrological oncologyEuropean Urology
researchProduct

Re: Chronic Bacterial Prostatitis: An Evolving Clinical Enigma

2006

Chronic bacterial prostatitisbusiness.industryUrologyImmunologyMedicinebusinessmedicine.diseaseEuropean Urology
researchProduct